Literature DB >> 19494730

Subjective improvement in proprioception in 2 patients with atypical Friedreich ataxia treated with varenicline (Chantix).

Theresa A Zesiewicz1, Kelly L Sullivan, Clifton L Gooch, David R Lynch.   

Abstract

Two patients with atypical Friedreich ataxia (heterozygotes for a GAA expansion and a G130V point mutation) experienced modest proprioceptive improvements in their extremities within a month of taking varenicline (Chantix), a drug approved for smoking cessation.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19494730     DOI： 10.1097/CND.0b013e3181910074

Source DB:  PubMed          Journal:  J Clin Neuromuscul Dis        ISSN： 1522-0443


  10 in total

1.  Functional correlates of gait and balance difficulty in essential tremor: balance confidence, near misses and falls.

Authors:  Elan D Louis; Ashwini K Rao; Marina Gerbin
Journal:  Gait Posture       Date:  2011-09-18       Impact factor: 2.840

Review 2.  Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders.

Authors:  Maryka Quik; James T Boyd; Tanuja Bordia; Xiomara Perez
Journal:  Nicotine Tob Res       Date:  2019-02-18       Impact factor: 4.244

3.  Long-term treatment with thiamine as possible medical therapy for Friedreich ataxia.

Authors:  Antonio Costantini; Tiziana Laureti; Maria Immacolata Pala; Marco Colangeli; Simona Cavalieri; Elisa Pozzi; Alfredo Brusco; Sandro Salvarani; Carlo Serrati; Roberto Fancellu
Journal:  J Neurol       Date:  2016-08-03       Impact factor: 4.849

4.  Therapeutic interventions in the primary hereditary ataxias.

Authors:  Gonzalo J Revuelta; George R Wilmot
Journal:  Curr Treat Options Neurol       Date:  2010-07       Impact factor: 3.598

5.  Atypical, perhaps under-recognized? An unusual phenotype of Friedreich ataxia.

Authors:  Beate Diehl; Michael S Lee; Janet R Reid; Craig D Nielsen; Marvin R Natowicz
Journal:  Neurogenetics       Date:  2010-02-17       Impact factor: 2.660

6.  Varenicline for the Treatment of Postural and Gait Dysfunction in Parkinson Disease.

Authors:  Sachin Kapur; Christina Vaughan; Jacob Hawkins; Glenn Stebbins; Deborah Hall
Journal:  Neurol Clin Pract       Date:  2021-12

7.  Neuronal nicotinic receptor agonists improve gait and balance in olivocerebellar ataxia.

Authors:  L Wecker; M E Engberg; R M Philpot; C S Lambert; C W Kang; J C Antilla; P C Bickford; C E Hudson; T A Zesiewicz; Peter P Rowell
Journal:  Neuropharmacology       Date:  2013-05-24       Impact factor: 5.250

Review 8.  Role for the nicotinic cholinergic system in movement disorders; therapeutic implications.

Authors:  Maryka Quik; Danhui Zhang; Xiomara A Perez; Tanuja Bordia
Journal:  Pharmacol Ther       Date:  2014-05-14       Impact factor: 12.310

Review 9.  Newly Approved and Investigational Drugs for Motor Symptom Control in Parkinson's Disease.

Authors:  Daniel Garbin Di Luca; Nikolai Gil D Reyes; Susan H Fox
Journal:  Drugs       Date:  2022-07-16       Impact factor: 11.431

10.  Varenicline improves motor and cognitive symptoms in early Huntington's disease.

Authors:  Ailsa L McGregor; Jo Dysart; Malcolm D Tingle; Bruce R Russell; Rob R Kydd; Gregory Finucane
Journal:  Neuropsychiatr Dis Treat       Date:  2016-09-19       Impact factor: 2.570
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.